Fundz

Marimed Completes Acquisition Of Kind Therapeutics Usa, A Maryland Vertically Integrated Cannabis Business

PUBLIC · MRMDApr 28, 2022

Acquiring Company

MariMed

Acquired Company

Kind Therapeutics USA

NorwoodCommunity And LifestyleConsumer GoodsHealth CareCannabisAlternative Medicine

Description

MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it completed the acquisition of Kind Therapeutics U.S.A., LLC (“Kind”), a leading vertically integrated cannabis business in Maryland.

Other recent acquisitions in Community And Lifestyle and Consumer Goods

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at MariMed, and when

When MariMed changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day MariMed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MariMed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MariMed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MariMed

Location

Norwood, Massachusetts, United States

About

MariMed Inc. is a multi-state cannabis operator dedicated to improving the lives of people every day through its products, actions, and values. The Company develops, owns, and manages state-licensed cannabis facilities, including growing and processing facilities as well as medical and adult-use retail dispensaries. MariMed is at the forefront of research and innovation, and its craft cannabis cultivation approach has resulted in a portfolio of premium, award-winning, and top-selling product brands, including Betty's Eddies fruit chews, Nature’s Heritage flower, and Vibations hydrating energy drink mix. The foundation of MariMed’s success is a culture of collaboration, compassion, and integrity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MariMed makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mario
Likely contact at this company
••••••••@••••••••

See Mario's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MariMed's next move

Learn about Strategic plan

Frequently asked

Who acquired Kind Therapeutics USA?

Kind Therapeutics USA was acquired by MariMed, based in Norwood. The deal was reported on April 28, 2022. MariMed Inc. is a multi-state cannabis operator dedicated to improving the lives of people every day through its products, actions, and values. MariMed is publicly traded (MRMD) and operates in Community And Lifestyle.

When did MariMed acquire Kind Therapeutics USA?

MariMed's acquisition of Kind Therapeutics USA was reported on April 28, 2022. MariMed Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Kind Therapeutics USA do?

Kind Therapeutics USA is the company acquired in this transaction. It is privately held.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.